| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 8 |
| 1 | PEMBROLIZUMAB | 8 |
| 2 | AZACITIDINE | 6 |
| 3 | AZACITIDINE FOR | 6 |
| 4 | CARBOPLATIN | 6 |
| 5 | NIVOLUMAB | 6 |
| 6 | BACLOFEN | 3 |
| 7 | CANDESARTAN | 3 |
| 8 | CYANOCOBALAMIN | 3 |
| 9 | DEXAMETHASONE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAROMOMYCIN SULFATE | 1 | 0.0094 |
| 1 | USTEKINUMAB-STBA | 1 | 0.0027 |
| 2 | SODIUM POLYSTYRENE SULFONATE | 1 | 0.0006 |
| 3 | TREMELIMUMAB | 1 | 0.0002 |
| 4 | AZACITIDINE | 6 | 0.0002 |
| 5 | IRBESARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0002 |
| 6 | URSOSIOL | 3 | 0.0002 |
| 7 | TEDUGLUTIDE | 2 | 0.0001 |
| 8 | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | 1 | 0.0001 |
| 9 | URSODIOL | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 14 | 0.0001 |
| 2 | Bile Acid [EPC] | 3 | 0.0001 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |
| 4 | Potassium Binder [EPC] | 1 | 0.0001 |
| 5 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 6 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 7 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 3 | 0.0000 |
| 8 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Rifamycin Antibacterial [EPC] | 1 | 0.0000 |